Verano Holdings (VRNO) Cash from Operations (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Cash from Operations of 18587000.0 for Q1 2026, up 940.71% year-over-year from 1786000.0 in Q1 2025, and up 34.54% quarter-over-quarter from 13815000.0 in Q4 2025.
Verano Holdings (VRNO) Cash from Operations (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Cash from Operations for 6 consecutive years, with 18587000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 940.71% year-over-year to 18587000.0; the TTM figure through Mar 2026 stood at 69656000.0 (down 16.02% YoY), while the FY2025 annual figure was 52855000.0, down 52.89% from the prior year.
- Cash from Operations advanced to 18587000.0 in Q1 2026 per VRNO's latest filing, from 13815000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 43501000.0 in Q4 2024 and bottomed at 1786000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 22805529.41 across 5 years, with a median of 23878000.0 in 2023.
- Annual changes were most pronounced in 2025 — Cash from Operations slumped 94.25% — and 2026, when it surged 940.71%.
- Verano Holdings' Cash from Operations stood at 29036000.0 in 2022, then rose by 11.41% to 32349000.0 in 2023, then surged by 34.47% to 43501000.0 in 2024, then plunged by 68.24% to 13815000.0 in 2025, then surged by 34.54% to 18587000.0 in 2026.
- Business Quant data shows VRNO's Cash from Operations at 18587000.0 in Q1 2026, 13815000.0 in Q4 2025, and 26354000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Verano Holdings | 449.04 Mn | 363.85 Mn | 99.70 Mn | 30.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.62 Mn |
| Jun 30, 2026 | 30.62 Mn |
| Mar 31, 2026 | 18.59 Mn |
| Mar 31, 2026 | 18.59 Mn |
| Dec 31, 2025 | 13.82 Mn |
| Dec 31, 2025 | 13.82 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Jun 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 10.90 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 43.50 Mn |
| Dec 31, 2024 | 43.50 Mn |
| Sep 30, 2024 | 29.73 Mn |
| Sep 30, 2024 | 29.73 Mn |
| Jun 30, 2024 | 7.92 Mn |
| Jun 30, 2024 | 7.92 Mn |
| Mar 31, 2024 | 31.04 Mn |
| Mar 31, 2024 | 31.04 Mn |